nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—Temozolomide—malignant glioma	0.342	1	CbGbCtD
Tiagabine—SLC6A1—cerebellar cortex—malignant glioma	0.116	0.503	CbGeAlD
Tiagabine—SLC6A1—brainstem—malignant glioma	0.0182	0.0791	CbGeAlD
Tiagabine—SLC6A1—retina—malignant glioma	0.0176	0.0763	CbGeAlD
Tiagabine—SLC6A1—telencephalon—malignant glioma	0.0162	0.0702	CbGeAlD
Tiagabine—SLC6A1—medulla oblongata—malignant glioma	0.0127	0.0552	CbGeAlD
Tiagabine—SLC6A1—midbrain—malignant glioma	0.0116	0.0504	CbGeAlD
Tiagabine—SLC6A1—spinal cord—malignant glioma	0.0113	0.0492	CbGeAlD
Tiagabine—SLC6A1—central nervous system—malignant glioma	0.00918	0.0399	CbGeAlD
Tiagabine—SLC6A1—cerebellum—malignant glioma	0.00897	0.039	CbGeAlD
Tiagabine—Hemiplegia—Carmustine—malignant glioma	0.00758	0.0205	CcSEcCtD
Tiagabine—Hemiplegia—Temozolomide—malignant glioma	0.00733	0.0198	CcSEcCtD
Tiagabine—SLC6A1—brain—malignant glioma	0.00729	0.0317	CbGeAlD
Tiagabine—Hyperacusis—Temozolomide—malignant glioma	0.00703	0.019	CcSEcCtD
Tiagabine—SLC6A1—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—malignant glioma	0.00686	0.118	CbGpPWpGaD
Tiagabine—Paranoid reaction—Carmustine—malignant glioma	0.00637	0.0172	CcSEcCtD
Tiagabine—Personality disorder—Carmustine—malignant glioma	0.00626	0.0169	CcSEcCtD
Tiagabine—Cerebral ischaemia—Temozolomide—malignant glioma	0.00542	0.0146	CcSEcCtD
Tiagabine—Faecal incontinence—Carmustine—malignant glioma	0.00537	0.0145	CcSEcCtD
Tiagabine—Faecal incontinence—Temozolomide—malignant glioma	0.00519	0.014	CcSEcCtD
Tiagabine—SLC6A1—Amine compound SLC transporters—SLC6A3—malignant glioma	0.00476	0.0819	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—SLC6A3—malignant glioma	0.00452	0.0778	CbGpPWpGaD
Tiagabine—Cerebration impaired—Temozolomide—malignant glioma	0.00445	0.012	CcSEcCtD
Tiagabine—Myasthenia—Carmustine—malignant glioma	0.00431	0.0116	CcSEcCtD
Tiagabine—Encephalopathy—Carmustine—malignant glioma	0.00422	0.0114	CcSEcCtD
Tiagabine—Parosmia—Temozolomide—malignant glioma	0.00404	0.0109	CcSEcCtD
Tiagabine—Hypokinesia—Carmustine—malignant glioma	0.00401	0.0108	CcSEcCtD
Tiagabine—Paranoia—Carmustine—malignant glioma	0.00397	0.0107	CcSEcCtD
Tiagabine—Apathy—Temozolomide—malignant glioma	0.00366	0.0099	CcSEcCtD
Tiagabine—Flat affect—Temozolomide—malignant glioma	0.00363	0.00981	CcSEcCtD
Tiagabine—Stupor—Carmustine—malignant glioma	0.00363	0.0098	CcSEcCtD
Tiagabine—Scotoma—Carmustine—malignant glioma	0.00357	0.00963	CcSEcCtD
Tiagabine—Menorrhagia—Temozolomide—malignant glioma	0.00354	0.00955	CcSEcCtD
Tiagabine—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00354	0.00955	CcSEcCtD
Tiagabine—SLC6A1—NRF2 pathway—FTH1—malignant glioma	0.00353	0.0607	CbGpPWpGaD
Tiagabine—Herpes zoster—Temozolomide—malignant glioma	0.00348	0.00939	CcSEcCtD
Tiagabine—Scotoma—Temozolomide—malignant glioma	0.00345	0.00931	CcSEcCtD
Tiagabine—Abscess—Carmustine—malignant glioma	0.00342	0.00925	CcSEcCtD
Tiagabine—Otitis media—Temozolomide—malignant glioma	0.00336	0.00908	CcSEcCtD
Tiagabine—Petechiae—Temozolomide—malignant glioma	0.00318	0.00859	CcSEcCtD
Tiagabine—Speech disorder—Carmustine—malignant glioma	0.00315	0.00851	CcSEcCtD
Tiagabine—Accidental injury—Carmustine—malignant glioma	0.00306	0.00827	CcSEcCtD
Tiagabine—Speech disorder—Temozolomide—malignant glioma	0.00304	0.00822	CcSEcCtD
Tiagabine—Disturbance in attention—Temozolomide—malignant glioma	0.00302	0.00816	CcSEcCtD
Tiagabine—Breast pain—Temozolomide—malignant glioma	0.003	0.0081	CcSEcCtD
Tiagabine—Amenorrhoea—Temozolomide—malignant glioma	0.00298	0.00805	CcSEcCtD
Tiagabine—Thinking abnormal—Carmustine—malignant glioma	0.00296	0.00799	CcSEcCtD
Tiagabine—Herpes simplex—Temozolomide—malignant glioma	0.00284	0.00767	CcSEcCtD
Tiagabine—Gait disturbance—Carmustine—malignant glioma	0.00277	0.0075	CcSEcCtD
Tiagabine—Coordination abnormal—Carmustine—malignant glioma	0.00276	0.00745	CcSEcCtD
Tiagabine—Neck pain—Carmustine—malignant glioma	0.00274	0.0074	CcSEcCtD
Tiagabine—Gait disturbance—Temozolomide—malignant glioma	0.00268	0.00724	CcSEcCtD
Tiagabine—Coordination abnormal—Temozolomide—malignant glioma	0.00267	0.0072	CcSEcCtD
Tiagabine—Vaginal inflammation—Temozolomide—malignant glioma	0.00262	0.00707	CcSEcCtD
Tiagabine—Urinary incontinence—Carmustine—malignant glioma	0.00262	0.00706	CcSEcCtD
Tiagabine—Depressed level of consciousness—Carmustine—malignant glioma	0.00262	0.00706	CcSEcCtD
Tiagabine—Depressed level of consciousness—Temozolomide—malignant glioma	0.00253	0.00683	CcSEcCtD
Tiagabine—Urinary incontinence—Temozolomide—malignant glioma	0.00253	0.00683	CcSEcCtD
Tiagabine—Coma—Carmustine—malignant glioma	0.00247	0.00669	CcSEcCtD
Tiagabine—Vaginal infection—Temozolomide—malignant glioma	0.00247	0.00667	CcSEcCtD
Tiagabine—Neoplasm—Carmustine—malignant glioma	0.00245	0.00661	CcSEcCtD
Tiagabine—Neoplasm—Temozolomide—malignant glioma	0.00237	0.00639	CcSEcCtD
Tiagabine—Abnormal vision—Carmustine—malignant glioma	0.00236	0.00638	CcSEcCtD
Tiagabine—Sepsis—Carmustine—malignant glioma	0.00235	0.00635	CcSEcCtD
Tiagabine—Mental disability—Carmustine—malignant glioma	0.00235	0.00635	CcSEcCtD
Tiagabine—Abnormal vision—Temozolomide—malignant glioma	0.00228	0.00617	CcSEcCtD
Tiagabine—Phlebitis—Carmustine—malignant glioma	0.00228	0.00616	CcSEcCtD
Tiagabine—Mental disability—Temozolomide—malignant glioma	0.00227	0.00614	CcSEcCtD
Tiagabine—Thrombophlebitis—Carmustine—malignant glioma	0.00227	0.00613	CcSEcCtD
Tiagabine—Ear pain—Temozolomide—malignant glioma	0.00223	0.00602	CcSEcCtD
Tiagabine—Thrombophlebitis—Temozolomide—malignant glioma	0.00219	0.00593	CcSEcCtD
Tiagabine—Eye pain—Carmustine—malignant glioma	0.00218	0.00588	CcSEcCtD
Tiagabine—Gastroenteritis—Temozolomide—malignant glioma	0.00214	0.00579	CcSEcCtD
Tiagabine—Injury—Carmustine—malignant glioma	0.00214	0.00578	CcSEcCtD
Tiagabine—Deafness—Temozolomide—malignant glioma	0.00212	0.00574	CcSEcCtD
Tiagabine—Eye pain—Temozolomide—malignant glioma	0.0021	0.00568	CcSEcCtD
Tiagabine—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00201	0.00544	CcSEcCtD
Tiagabine—Thirst—Temozolomide—malignant glioma	0.002	0.00539	CcSEcCtD
Tiagabine—Hyponatraemia—Carmustine—malignant glioma	0.00197	0.00533	CcSEcCtD
Tiagabine—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00197	0.00531	CcSEcCtD
Tiagabine—Diplopia—Carmustine—malignant glioma	0.00197	0.00531	CcSEcCtD
Tiagabine—Diplopia—Temozolomide—malignant glioma	0.0019	0.00513	CcSEcCtD
Tiagabine—Face oedema—Carmustine—malignant glioma	0.0019	0.00513	CcSEcCtD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00189	0.0325	CbGpPWpGaD
Tiagabine—Affect lability—Temozolomide—malignant glioma	0.00187	0.00505	CcSEcCtD
Tiagabine—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00186	0.032	CbGpPWpGaD
Tiagabine—Ataxia—Carmustine—malignant glioma	0.00185	0.00499	CcSEcCtD
Tiagabine—SLC6A1—Monoamine Transport—IL1B—malignant glioma	0.00184	0.0317	CbGpPWpGaD
Tiagabine—Face oedema—Temozolomide—malignant glioma	0.00183	0.00495	CcSEcCtD
Tiagabine—Liver function test abnormal—Carmustine—malignant glioma	0.00181	0.0049	CcSEcCtD
Tiagabine—Mood swings—Temozolomide—malignant glioma	0.0018	0.00486	CcSEcCtD
Tiagabine—Hypokalaemia—Carmustine—malignant glioma	0.00179	0.00483	CcSEcCtD
Tiagabine—Ataxia—Temozolomide—malignant glioma	0.00179	0.00483	CcSEcCtD
Tiagabine—Dehydration—Temozolomide—malignant glioma	0.00177	0.00477	CcSEcCtD
Tiagabine—Dry skin—Temozolomide—malignant glioma	0.00174	0.0047	CcSEcCtD
Tiagabine—Muscular weakness—Carmustine—malignant glioma	0.00173	0.00468	CcSEcCtD
Tiagabine—Hypokalaemia—Temozolomide—malignant glioma	0.00173	0.00467	CcSEcCtD
Tiagabine—Dysphagia—Carmustine—malignant glioma	0.0017	0.00459	CcSEcCtD
Tiagabine—Muscular weakness—Temozolomide—malignant glioma	0.00168	0.00453	CcSEcCtD
Tiagabine—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.00167	0.0287	CbGpPWpGaD
Tiagabine—Dysphagia—Temozolomide—malignant glioma	0.00164	0.00444	CcSEcCtD
Tiagabine—Bronchitis—Temozolomide—malignant glioma	0.00158	0.00427	CcSEcCtD
Tiagabine—Dysuria—Temozolomide—malignant glioma	0.00154	0.00415	CcSEcCtD
Tiagabine—Hyperglycaemia—Carmustine—malignant glioma	0.00153	0.00414	CcSEcCtD
Tiagabine—Pneumonia—Carmustine—malignant glioma	0.00152	0.00412	CcSEcCtD
Tiagabine—Pollakiuria—Temozolomide—malignant glioma	0.00152	0.0041	CcSEcCtD
Tiagabine—Erectile dysfunction—Temozolomide—malignant glioma	0.00151	0.00409	CcSEcCtD
Tiagabine—Depression—Carmustine—malignant glioma	0.00151	0.00408	CcSEcCtD
Tiagabine—Photosensitivity reaction—Temozolomide—malignant glioma	0.0015	0.00405	CcSEcCtD
Tiagabine—Weight increased—Temozolomide—malignant glioma	0.00149	0.00404	CcSEcCtD
Tiagabine—Renal failure—Carmustine—malignant glioma	0.00149	0.00402	CcSEcCtD
Tiagabine—Weight decreased—Temozolomide—malignant glioma	0.00149	0.00401	CcSEcCtD
Tiagabine—Neuropathy peripheral—Carmustine—malignant glioma	0.00149	0.00401	CcSEcCtD
Tiagabine—Hyperglycaemia—Temozolomide—malignant glioma	0.00148	0.004	CcSEcCtD
Tiagabine—Stomatitis—Carmustine—malignant glioma	0.00148	0.00399	CcSEcCtD
Tiagabine—Urinary tract infection—Carmustine—malignant glioma	0.00147	0.00398	CcSEcCtD
Tiagabine—Pneumonia—Temozolomide—malignant glioma	0.00147	0.00398	CcSEcCtD
Tiagabine—Depression—Temozolomide—malignant glioma	0.00146	0.00394	CcSEcCtD
Tiagabine—CYP3A4—central nervous system—malignant glioma	0.00144	0.00625	CbGeAlD
Tiagabine—Neuropathy peripheral—Temozolomide—malignant glioma	0.00144	0.00388	CcSEcCtD
Tiagabine—Stomatitis—Temozolomide—malignant glioma	0.00143	0.00386	CcSEcCtD
Tiagabine—Urinary tract infection—Temozolomide—malignant glioma	0.00142	0.00384	CcSEcCtD
Tiagabine—SLC6A1—NRF2 pathway—SLC5A5—malignant glioma	0.00141	0.0243	CbGpPWpGaD
Tiagabine—Sinusitis—Temozolomide—malignant glioma	0.00137	0.00371	CcSEcCtD
Tiagabine—Haemoglobin—Carmustine—malignant glioma	0.00137	0.00369	CcSEcCtD
Tiagabine—Haemorrhage—Carmustine—malignant glioma	0.00136	0.00367	CcSEcCtD
Tiagabine—Hallucination—Carmustine—malignant glioma	0.00135	0.00366	CcSEcCtD
Tiagabine—Hypoaesthesia—Carmustine—malignant glioma	0.00135	0.00366	CcSEcCtD
Tiagabine—SLC6A1—NRF2 pathway—SLC6A3—malignant glioma	0.00134	0.0231	CbGpPWpGaD
Tiagabine—Oedema peripheral—Carmustine—malignant glioma	0.00134	0.00362	CcSEcCtD
Tiagabine—SLC6A1—Monoamine Transport—TNF—malignant glioma	0.00134	0.023	CbGpPWpGaD
Tiagabine—Haemoglobin—Temozolomide—malignant glioma	0.00132	0.00357	CcSEcCtD
Tiagabine—Haemorrhage—Temozolomide—malignant glioma	0.00131	0.00355	CcSEcCtD
Tiagabine—Visual impairment—Carmustine—malignant glioma	0.00131	0.00354	CcSEcCtD
Tiagabine—Hallucination—Temozolomide—malignant glioma	0.00131	0.00353	CcSEcCtD
Tiagabine—Hypoaesthesia—Temozolomide—malignant glioma	0.00131	0.00353	CcSEcCtD
Tiagabine—Pharyngitis—Temozolomide—malignant glioma	0.0013	0.00352	CcSEcCtD
Tiagabine—Oedema peripheral—Temozolomide—malignant glioma	0.00129	0.0035	CcSEcCtD
Tiagabine—Visual impairment—Temozolomide—malignant glioma	0.00127	0.00342	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00124	0.0213	CbGpPWpGaD
Tiagabine—Tinnitus—Temozolomide—malignant glioma	0.00123	0.00331	CcSEcCtD
Tiagabine—Alopecia—Carmustine—malignant glioma	0.0012	0.00325	CcSEcCtD
Tiagabine—Chills—Temozolomide—malignant glioma	0.00118	0.00319	CcSEcCtD
Tiagabine—Alopecia—Temozolomide—malignant glioma	0.00116	0.00314	CcSEcCtD
Tiagabine—Back pain—Carmustine—malignant glioma	0.00115	0.00309	CcSEcCtD
Tiagabine—SLC6A1—NRF2 pathway—GSTP1—malignant glioma	0.00114	0.0196	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00113	0.0194	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.00113	0.0194	CbGpPWpGaD
Tiagabine—Dysgeusia—Temozolomide—malignant glioma	0.00112	0.00303	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—BCHE—malignant glioma	0.00111	0.0191	CbGpPWpGaD
Tiagabine—Tremor—Carmustine—malignant glioma	0.00111	0.003	CcSEcCtD
Tiagabine—Back pain—Temozolomide—malignant glioma	0.00111	0.00299	CcSEcCtD
Tiagabine—Anaemia—Carmustine—malignant glioma	0.00109	0.00296	CcSEcCtD
Tiagabine—Agitation—Carmustine—malignant glioma	0.00109	0.00294	CcSEcCtD
Tiagabine—Tremor—Temozolomide—malignant glioma	0.00107	0.0029	CcSEcCtD
Tiagabine—Ill-defined disorder—Temozolomide—malignant glioma	0.00106	0.00287	CcSEcCtD
Tiagabine—Leukopenia—Carmustine—malignant glioma	0.00106	0.00286	CcSEcCtD
Tiagabine—Anaemia—Temozolomide—malignant glioma	0.00106	0.00286	CcSEcCtD
Tiagabine—Agitation—Temozolomide—malignant glioma	0.00105	0.00284	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.00104	0.018	CbGpPWpGaD
Tiagabine—Malaise—Temozolomide—malignant glioma	0.00103	0.00279	CcSEcCtD
Tiagabine—Vertigo—Temozolomide—malignant glioma	0.00103	0.00278	CcSEcCtD
Tiagabine—Leukopenia—Temozolomide—malignant glioma	0.00102	0.00277	CcSEcCtD
Tiagabine—Hypertension—Carmustine—malignant glioma	0.00102	0.00276	CcSEcCtD
Tiagabine—Palpitations—Temozolomide—malignant glioma	0.00101	0.00273	CcSEcCtD
Tiagabine—Myalgia—Carmustine—malignant glioma	0.00101	0.00272	CcSEcCtD
Tiagabine—Chest pain—Carmustine—malignant glioma	0.00101	0.00272	CcSEcCtD
Tiagabine—Anxiety—Carmustine—malignant glioma	0.001	0.00271	CcSEcCtD
Tiagabine—Cough—Temozolomide—malignant glioma	0.000998	0.0027	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.000988	0.017	CbGpPWpGaD
Tiagabine—Hypertension—Temozolomide—malignant glioma	0.000988	0.00267	CcSEcCtD
Tiagabine—Confusional state—Carmustine—malignant glioma	0.000974	0.00263	CcSEcCtD
Tiagabine—Myalgia—Temozolomide—malignant glioma	0.000974	0.00263	CcSEcCtD
Tiagabine—Arthralgia—Temozolomide—malignant glioma	0.000974	0.00263	CcSEcCtD
Tiagabine—Anxiety—Temozolomide—malignant glioma	0.000971	0.00262	CcSEcCtD
Tiagabine—Oedema—Carmustine—malignant glioma	0.000966	0.00261	CcSEcCtD
Tiagabine—Discomfort—Temozolomide—malignant glioma	0.000962	0.0026	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—APOD—malignant glioma	0.000961	0.0165	CbGpPWpGaD
Tiagabine—Infection—Carmustine—malignant glioma	0.00096	0.00259	CcSEcCtD
Tiagabine—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.000959	0.0165	CbGpPWpGaD
Tiagabine—Dry mouth—Temozolomide—malignant glioma	0.000953	0.00257	CcSEcCtD
Tiagabine—Thrombocytopenia—Carmustine—malignant glioma	0.000946	0.00256	CcSEcCtD
Tiagabine—Tachycardia—Carmustine—malignant glioma	0.000943	0.00255	CcSEcCtD
Tiagabine—Confusional state—Temozolomide—malignant glioma	0.000941	0.00254	CcSEcCtD
Tiagabine—Oedema—Temozolomide—malignant glioma	0.000934	0.00252	CcSEcCtD
Tiagabine—Infection—Temozolomide—malignant glioma	0.000928	0.00251	CcSEcCtD
Tiagabine—Anorexia—Carmustine—malignant glioma	0.000921	0.00249	CcSEcCtD
Tiagabine—Thrombocytopenia—Temozolomide—malignant glioma	0.000914	0.00247	CcSEcCtD
Tiagabine—Hypotension—Carmustine—malignant glioma	0.000903	0.00244	CcSEcCtD
Tiagabine—Hyperhidrosis—Temozolomide—malignant glioma	0.000903	0.00244	CcSEcCtD
Tiagabine—SLC6A1—NRF2 pathway—PDGFB—malignant glioma	0.000898	0.0155	CbGpPWpGaD
Tiagabine—Anorexia—Temozolomide—malignant glioma	0.00089	0.0024	CcSEcCtD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.000889	0.0153	CbGpPWpGaD
Tiagabine—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00088	0.00238	CcSEcCtD
Tiagabine—Insomnia—Carmustine—malignant glioma	0.000874	0.00236	CcSEcCtD
Tiagabine—Paraesthesia—Carmustine—malignant glioma	0.000868	0.00234	CcSEcCtD
Tiagabine—Dyspnoea—Carmustine—malignant glioma	0.000861	0.00233	CcSEcCtD
Tiagabine—Somnolence—Carmustine—malignant glioma	0.000859	0.00232	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—BCHE—malignant glioma	0.000851	0.0146	CbGpPWpGaD
Tiagabine—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000851	0.0023	CcSEcCtD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.000846	0.0146	CbGpPWpGaD
Tiagabine—Insomnia—Temozolomide—malignant glioma	0.000845	0.00228	CcSEcCtD
Tiagabine—Decreased appetite—Carmustine—malignant glioma	0.00084	0.00227	CcSEcCtD
Tiagabine—Paraesthesia—Temozolomide—malignant glioma	0.000838	0.00227	CcSEcCtD
Tiagabine—Dyspnoea—Temozolomide—malignant glioma	0.000832	0.00225	CcSEcCtD
Tiagabine—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.000832	0.0143	CbGpPWpGaD
Tiagabine—Somnolence—Temozolomide—malignant glioma	0.00083	0.00224	CcSEcCtD
Tiagabine—Pain—Carmustine—malignant glioma	0.000826	0.00223	CcSEcCtD
Tiagabine—Constipation—Carmustine—malignant glioma	0.000826	0.00223	CcSEcCtD
Tiagabine—Dyspepsia—Temozolomide—malignant glioma	0.000822	0.00222	CcSEcCtD
Tiagabine—Decreased appetite—Temozolomide—malignant glioma	0.000812	0.00219	CcSEcCtD
Tiagabine—Fatigue—Temozolomide—malignant glioma	0.000805	0.00217	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—SLC6A3—malignant glioma	0.0008	0.0138	CbGpPWpGaD
Tiagabine—Pain—Temozolomide—malignant glioma	0.000798	0.00216	CcSEcCtD
Tiagabine—Constipation—Temozolomide—malignant glioma	0.000798	0.00216	CcSEcCtD
Tiagabine—Feeling abnormal—Carmustine—malignant glioma	0.000796	0.00215	CcSEcCtD
Tiagabine—Gastrointestinal pain—Carmustine—malignant glioma	0.00079	0.00213	CcSEcCtD
Tiagabine—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.000779	0.0134	CbGpPWpGaD
Tiagabine—Feeling abnormal—Temozolomide—malignant glioma	0.000769	0.00208	CcSEcCtD
Tiagabine—Body temperature increased—Carmustine—malignant glioma	0.000764	0.00206	CcSEcCtD
Tiagabine—Abdominal pain—Carmustine—malignant glioma	0.000764	0.00206	CcSEcCtD
Tiagabine—Gastrointestinal pain—Temozolomide—malignant glioma	0.000764	0.00206	CcSEcCtD
Tiagabine—Urticaria—Temozolomide—malignant glioma	0.000742	0.002	CcSEcCtD
Tiagabine—Abdominal pain—Temozolomide—malignant glioma	0.000738	0.00199	CcSEcCtD
Tiagabine—Body temperature increased—Temozolomide—malignant glioma	0.000738	0.00199	CcSEcCtD
Tiagabine—Hypersensitivity—Carmustine—malignant glioma	0.000712	0.00192	CcSEcCtD
Tiagabine—Asthenia—Carmustine—malignant glioma	0.000693	0.00187	CcSEcCtD
Tiagabine—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.000691	0.0119	CbGpPWpGaD
Tiagabine—Hypersensitivity—Temozolomide—malignant glioma	0.000688	0.00186	CcSEcCtD
Tiagabine—Asthenia—Temozolomide—malignant glioma	0.00067	0.00181	CcSEcCtD
Tiagabine—Diarrhoea—Carmustine—malignant glioma	0.000661	0.00179	CcSEcCtD
Tiagabine—Pruritus—Temozolomide—malignant glioma	0.000661	0.00178	CcSEcCtD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000659	0.0113	CbGpPWpGaD
Tiagabine—Dizziness—Carmustine—malignant glioma	0.000639	0.00173	CcSEcCtD
Tiagabine—Diarrhoea—Temozolomide—malignant glioma	0.000639	0.00173	CcSEcCtD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000627	0.0108	CbGpPWpGaD
Tiagabine—Dizziness—Temozolomide—malignant glioma	0.000617	0.00167	CcSEcCtD
Tiagabine—Vomiting—Carmustine—malignant glioma	0.000614	0.00166	CcSEcCtD
Tiagabine—Rash—Carmustine—malignant glioma	0.000609	0.00165	CcSEcCtD
Tiagabine—Dermatitis—Carmustine—malignant glioma	0.000609	0.00164	CcSEcCtD
Tiagabine—Headache—Carmustine—malignant glioma	0.000605	0.00164	CcSEcCtD
Tiagabine—Vomiting—Temozolomide—malignant glioma	0.000594	0.0016	CcSEcCtD
Tiagabine—Rash—Temozolomide—malignant glioma	0.000589	0.00159	CcSEcCtD
Tiagabine—Dermatitis—Temozolomide—malignant glioma	0.000588	0.00159	CcSEcCtD
Tiagabine—Headache—Temozolomide—malignant glioma	0.000585	0.00158	CcSEcCtD
Tiagabine—Nausea—Carmustine—malignant glioma	0.000574	0.00155	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000567	0.00975	CbGpPWpGaD
Tiagabine—Nausea—Temozolomide—malignant glioma	0.000555	0.0015	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—TFRC—malignant glioma	0.000492	0.00846	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000475	0.00817	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000473	0.00814	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.000452	0.00777	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—BRAF—malignant glioma	0.000434	0.00747	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00043	0.0074	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000427	0.00735	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000423	0.00728	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000398	0.00685	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000393	0.00676	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—MDM2—malignant glioma	0.000364	0.00626	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—RAF1—malignant glioma	0.000363	0.00624	CbGpPWpGaD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000345	0.00594	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000341	0.00586	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000323	0.00555	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.00028	0.00482	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000233	0.00401	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000212	0.00365	CbGpPWpGaD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000201	0.00345	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000195	0.00335	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	0.000172	0.00295	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	0.000169	0.00291	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	0.000149	0.00256	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	0.000147	0.00252	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	0.000129	0.00221	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTT1—malignant glioma	0.00012	0.00207	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—PTGS1—malignant glioma	0.000113	0.00194	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—RTEL1—malignant glioma	8.43e-05	0.00145	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTP1—malignant glioma	8.34e-05	0.00143	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	8.22e-05	0.00141	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—COX8A—malignant glioma	4.84e-05	0.000833	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ASMT—malignant glioma	4.12e-05	0.000708	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—BCAN—malignant glioma	3.87e-05	0.000666	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—IDH2—malignant glioma	3.12e-05	0.000537	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.93e-05	0.000505	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—IDH1—malignant glioma	2.68e-05	0.000461	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SPHK1—malignant glioma	2.6e-05	0.000447	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.54e-05	0.000437	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTT1—malignant glioma	2.06e-05	0.000354	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGS1—malignant glioma	1.93e-05	0.000332	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—BCHE—malignant glioma	1.79e-05	0.000308	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.77e-05	0.000304	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTP1—malignant glioma	1.43e-05	0.000245	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CAT—malignant glioma	1.39e-05	0.000239	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—NCOR1—malignant glioma	1.31e-05	0.000225	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CAV1—malignant glioma	1.07e-05	0.000184	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CG—malignant glioma	9.73e-06	0.000167	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPARG—malignant glioma	9.39e-06	0.000162	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CD—malignant glioma	8.55e-06	0.000147	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CB—malignant glioma	7.45e-06	0.000128	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGS2—malignant glioma	7.39e-06	0.000127	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTEN—malignant glioma	6.44e-06	0.000111	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.54e-06	7.82e-05	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—AKT1—malignant glioma	3.71e-06	6.39e-05	CbGpPWpGaD
